Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer - Concepedia

Concepedia

Publication | Open Access

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

DOI Full Paper Access

930

Citations

53

References

2018

Year

JoAnn E. Manson, Nancy R. Cook, I‐Min Lee, William G. Christen, Shari S. Bassuk, Samia Mora, Heike Gibson, Christine M. Albert, David Gordon, Trisha Copeland,

New England Journal of Medicine

Abstract

Supplementation with n-3 fatty acids did not result in a lower incidence of major cardiovascular events or cancer than placebo. (Funded by the National Institutes of Health and others; VITAL ClinicalTrials.gov number, NCT01169259 .).

References

	Year	Citations
A Proportional Hazards Model for the Subdistribution of a Competing Risk Jason P. Fine Journal of the American Statistical Association PrognosisRare Event EstimationRisk MetricRisk AnalysisEmerging Risk	1999	13.2K
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Harold P. Adams, Birgitte H. Bendixen, L. Jaap Kappelle, Stroke	1993	12K
Prevalence of Overweight and Obesity in the United States, 1999-2004 Cynthia L. Ogden, Margaret D. Carroll, Lester R. Curtin, JAMA	2006	8.7K
Isolated Hand Paresis: A Case Series Karl Bjørnar Alstadhaug, Ane Skaare Sjulstad Cerebrovascular Diseases Extra	2013	4.1K
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial The Lancet Vitamin ENutritionCardiovascular DiseaseOmega-3 Fatty AcidLipid Nutrition	1999	3.8K
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Penny M. Kris‐Etherton, William S. Harris, Lawrence J. Appel Circulation ObesityMetabolic SyndromeNutritionCardiovascular DiseaseHealth Policy	2002	3.7K
A Multiple Testing Procedure for Clinical Trials Peter C. O’Brien, Thomas R. Fleming Biometrics Multiple Testing ProcedurePsychiatryClinical Trial ManagementHealth PolicyTreatment Plan Evaluation	1979	3.3K
Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Kristian Thygesen Circulation Cardiovascular DiseaseUniversal DefinitionMedicineCardiologyEmergency Medicine	2007	3.1K
Third Universal Definition of Myocardial Infarction Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Circulation	2012	2.9K
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki, The Lancet Metabolic SyndromeHypercholesterolaemic PatientsCardiovascular DiseaseEndpoint AnalysisMedicine	2007	2.5K

Page 1